Fast Company: “Strategic partnerships in health care services: An untapped resource for accelerating growth”
Fast Company: “Strategic partnerships in health care services: An untapped resource for accelerating growth” Roy Bejarano, Co-Founder and CEO of SCALE Healthcare Strategic partnerships are one of health care’s most underdeveloped […]
National, Federal and State Policy Updates: September 1, 2022
National, Federal and State Policy Updates: September 2022 Federal Policy Updates CMS Releases 2021 MSSP Performance Data On August 30, CMS released financial and quality data for the Medicare Shared […]
National, Federal and State Policy Updates: August 1, 2022
National, Federal and State Policy Updates: July 20, 2022 Spotlight on Pediatrics On August 1, CMS outlined a roadmap for a new state Medicaid option in a federal guidance document […]
SCALE Healthcare Announces Expansion Plans with the Addition of Six New Subsidiaries and the Launch of a New Online Healthcare Education Program
SCALE Healthcare has quickly risen in the US to become the leader in healthcare services consulting through its singular focus on helping management teams build modernized healthcare delivery systems that yield […]
National, Federal and State Policy Updates: July 20, 2022
National, Federal and State Policy Updates: July 20, 2022 Spotlight on Oncology On June 27, CMS introduced the Enhancing Oncology Model, a voluntary 5-year model that refines the recently concluded […]
National, Federal and State Policy Updates: June 22, 2022
National, Federal and State Policy Updates: June 22, 2022 National Policy Update Spotlight on LGBT Health In June, the Medicaid and CHIP Payment and Access Commission (MACPAC) released an issue […]
National, Federal & State Policy Update: June 17, 2022
Healthcare Policy Update: June 17, 2022 National Policy Update Spotlight on Maternal Health On May 31, the American Hospital Association hosted a dialogue on the use of investment funds to […]
National, Federal & State Policy Update: June 1, 2022
Healthcare Policy Update: June 1, 2022 National Policy Update Spotlight on Behavioral Health On March 23, Senators Patty Murray (D-WA) and Richard Burr (R-NC) held a hearing on addressing mental […]
Limited Uptake of Biosimilars Despite Potential Cost Savings
Limited Uptake of Biosimilars Despite Potential Cost Savings: Patent Expiration and Value-Based Contracting to Drive Market Changes Summary: Biosimilars are drugs that reference a biologic and are concentrated in high-cost […]